[
  {
    "ts": null,
    "headline": "3 Low-Volatility Stocks That Concern Us",
    "summary": "Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.",
    "url": "https://finnhub.io/api/news?id=29234e6f7679b448a3c12b6a241fb00a711836bd65e8fb8b7e4c5b9e851c0ef0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759380156,
      "headline": "3 Low-Volatility Stocks That Concern Us",
      "id": 136955711,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.",
      "url": "https://finnhub.io/api/news?id=29234e6f7679b448a3c12b6a241fb00a711836bd65e8fb8b7e4c5b9e851c0ef0"
    }
  },
  {
    "ts": null,
    "headline": "Jefferies Initiates Coverage on Biogen Inc. (BIIB) with Buy Rating and $190 PT",
    "summary": "With significant upside potential, Biogen Inc. (NASDAQ:BIIB) secures a spot on our list of the 12 Best Widow and Orphan Stocks to Buy According to Analysts. Jefferies began covering Biogen Inc. (NASDAQ:BIIB) on September 26 with a Buy rating and a price target of $190. The firm argued that despite the company’s significant strategic and […]",
    "url": "https://finnhub.io/api/news?id=ed63630ba9a138bf67fbc346fbad0b27f3bb3ab592857010099308952b1a637d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759364183,
      "headline": "Jefferies Initiates Coverage on Biogen Inc. (BIIB) with Buy Rating and $190 PT",
      "id": 136952637,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "With significant upside potential, Biogen Inc. (NASDAQ:BIIB) secures a spot on our list of the 12 Best Widow and Orphan Stocks to Buy According to Analysts. Jefferies began covering Biogen Inc. (NASDAQ:BIIB) on September 26 with a Buy rating and a price target of $190. The firm argued that despite the company’s significant strategic and […]",
      "url": "https://finnhub.io/api/news?id=ed63630ba9a138bf67fbc346fbad0b27f3bb3ab592857010099308952b1a637d"
    }
  }
]